[Hepatic damage in patients treated with rifampicin (author's transl)].
D001219:Aspartate Aminotransferases / Q000097:blood; D001706:Biopsy; D002462:Cell Membrane / Q000187:drug effects; D056486:Chemical and Drug Induced Liver Injury; D003593:Cytoplasm / Q000187:drug effects; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000009:adverse effects; D006801:Humans; D008134:Long-Term Care; D008854:Microscopy, Electron; D008875:Middle Aged; D008930:Mitochondria, Liver / Q000187:drug effects; D012293:Rifampin / Q000009:adverse effects*
D004977:Ethambutol; D001219:Aspartate Aminotransferases; D012293:Rifampin
Leberschädigung bei mit Rifampicin behandelten Patienten